反応式
FC(F)(F)C(O)=O.[F:8][C:9]1[CH:14]=[C:13]([N:15]2[CH:19]=[N:18][N:17]=[N:16]2)[CH:12]=[CH:11][C:10]=1[C:20]1[CH:21]=[CH:22][C:23]2[O:27][C:26]([CH:28]3[CH2:33][CH2:32][NH:31][CH2:30][CH2:29]3)=[N:25][C:24]=2[CH:34]=1.C([O-])([O-])=O.[K+].[K+].CS(O[CH2:46][CH2:47][O:48][CH3:49])(=O)=O.CCOC(C)=O.O>CN(C=O)C>[F:8][C:9]1[CH:14]=[C:13]([N:15]2[CH:19]=[N:18][N:17]=[N:16]2)[CH:12]=[CH:11][C:10]=1[C:20]1[CH:21]=[CH:22][C:23]2[O:27][C:26]([CH:28]3[CH2:29][CH2:30][N:31]([CH2:46][CH2:47][O:48][CH3:49])[CH2:32][CH2:33]3)=[N:25][C:24]=2[CH:34]=1参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
実験手順
5-[2-fluoro-4-(1H-tetrazol-1-yl)-phenyl]-2-(piperidin-4-yl)-benzo[d]oxazole 2,2,2-trifluoroacetate (30 mg, 0.06 mmol) was dissolved in DMF (2 ml) and added K2CO3 (40 mg, 0.29 mmol) and stirred the mixture at rt for 15 mins. To this mixture added 2-methoxyethyl methanesulfonate (45 mg, 0.29 mmol) and stirred at rt for 17 h. Work up (EtOAc/H2O) followed by purification by column chromatography on 60-120 mesh silicagel using a gradient mixture of DCM and MeOH (98:2) as eluent afforded the titled compound (90 mg) as a brown solid (15 mg). M.P.: 148-152° C. MS (m/z): 423.3 [M+H]+.
後処理
- stirringstirred at rt for 17 h
- customfollowed by purification by column chromatography on 60-120 mesh silicagel
- additiona gradient mixture of DCM and MeOH (98:2) as eluent
出典と根拠
- ORDレコード
- ord-f1ee3165eaf94bba8b8407aa14598622
- 出典データセット
- uspto-grants-2015_11
- 特許番号
- US09181214B2
関連ノート
読み込み中…